Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash & Current Investments (2016 - 2025)

Aethlon Medical filings provide 15 years of Cash & Current Investments readings, the most recent being $5.5 million for Q1 2025.

  • On a quarterly basis, Cash & Current Investments fell 0.51% to $5.5 million in Q1 2025 year-over-year; TTM through Mar 2025 was $5.5 million, a 0.51% decrease, with the full-year FY2025 number at $5.5 million, down 0.51% from a year prior.
  • Cash & Current Investments hit $5.5 million in Q1 2025 for Aethlon Medical, up from $4.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $25.2 million in Q2 2021 to a low of $4.9 million in Q4 2024.
  • Median Cash & Current Investments over the past 5 years was $13.0 million (2023), compared with a mean of $13.3 million.
  • Biggest five-year swings in Cash & Current Investments: surged 73.19% in 2022 and later tumbled 62.18% in 2024.
  • Aethlon Medical's Cash & Current Investments stood at $20.5 million in 2021, then dropped by 14.56% to $17.5 million in 2022, then plummeted by 54.44% to $8.0 million in 2023, then crashed by 38.37% to $4.9 million in 2024, then rose by 11.98% to $5.5 million in 2025.
  • The last three reported values for Cash & Current Investments were $5.5 million (Q1 2025), $4.9 million (Q4 2024), and $6.9 million (Q3 2024) per Business Quant data.